Pub Date : 1900-01-01DOI: 10.25179/tjem.2018-63374
B. Bolayır, Damla Okay, M. Akturk, M. Akın, A. Poyraz, A. Sel, B. Yilmaz, A. Altinova, F. Törüner, N. Çakır
{"title":"Adrenocorticotropic Hormon-Secreting Pheochromocytoma: A Rare Cause of Cushing’s Syndrome","authors":"B. Bolayır, Damla Okay, M. Akturk, M. Akın, A. Poyraz, A. Sel, B. Yilmaz, A. Altinova, F. Törüner, N. Çakır","doi":"10.25179/tjem.2018-63374","DOIUrl":"https://doi.org/10.25179/tjem.2018-63374","url":null,"abstract":"","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115872216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2019-70735
Ö. Topaloğlu, B. Evren, S. Yoloğlu, Ş. Şahin, I. Sahin
{"title":"The Frequency of Vitamin D Deficiency in Obese Patients on Bariatric Surgery Wait List: Is there any Association with Co-existence of Prediabetes or Diabetes?","authors":"Ö. Topaloğlu, B. Evren, S. Yoloğlu, Ş. Şahin, I. Sahin","doi":"10.25179/tjem.2019-70735","DOIUrl":"https://doi.org/10.25179/tjem.2019-70735","url":null,"abstract":"","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124786117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2021-84279
Mustafa Ünübol, Zehra Erdemir, Gokhan Colak, M. Ünsal, Engin Güney
Subacute thyroiditis (SAT) is granulomatous thyroiditis of the thyroid gland that usually occurs after a viral infection. Coronavirus disease-2019 (COVID-19) infection has led to a pandemic that has affected the whole world since late 2019. The virus has been reported to cause different extrapulmonary clinical symptoms. Few cases in the literature have reported SAT after COVID-19 viral infection. In this article, 2 cases were diagnosed, where SAT was presented after COVID-19 infection. Using these cases, we aimed to emphasize that patients who present with pain and tenderness in the anterior neck region after COVID-19 infection may develop SAT, whose diagnosis can be missed. Subakut tiroidit (SAT), genellikle bir viral enfeksiyondan sonra ortaya çıkan tiroid bezinin granülomatöz bir tiroiditidir. Koronavirüs hastalığı-2019 [coronavirus disease-2019 (COVID-19)] enfeksiyonu, 2019 yılının sonundan beri tüm dünyayı etkileyen bir pandemiye yol açmıştır. Ekstrapulmoner birçok farklı klinik tabloya yol açtığı bildirilmiştir. COVID-19 viral enfeksiyonu sonrasında SAT bildirilen olgular literatürde az sayıdadır. Bu yazıda, COVID-19 enfeksiyonu sonrası SAT tanısı olan 2 olgu sunuldu. Bu olgular ile birlikte COVID-19 enfeksiyonu sonrası özellikle ön boyun bölgesinde ağrı ve hassasiyet gelişen olgularda atlanabilen bir tanı olarak SAT gelişebileceğini vurgulamak istemekteyiz.
亚急性甲状腺炎(SAT)是甲状腺肉芽肿性甲状腺炎，通常发生在病毒感染后。自2019年底以来，冠状病毒病-2019 (COVID-19)感染导致了一场影响全球的大流行。据报道，该病毒可引起不同的肺外临床症状。文献中很少有病例报道COVID-19病毒感染后出现SAT。在本文中，2例确诊病例在COVID-19感染后出现SAT。通过这些病例，我们旨在强调COVID-19感染后颈部前区出现疼痛和压痛的患者可能会发展为SAT，其诊断可能会被遗漏。Subakut tiroidit (SAT)，类鸟病毒enfeksiyondan sonra ortaya çıkan类鸟嘌呤granülomatöz类鸟嘌呤。koronavir s hastalığı-2019[冠状病毒病-2019 (COVID-19)] enfeksiyonu, 2019 yılının sonundan beri t m dnyayyi etkileyen b流行病]açmıştır。Ekstrapulmoner birok farklikklinik tabloya yol açtığı bildirilmitir。COVID-19病毒enfeksiyonu sonrasında SAT bildiilen分子文献 sayıdadır。但是yazıda, COVID-19 enfeksiyonu sonrasyi SAT tanısı olan 2 olgu sunuldu。但是，像COVID-19一样的流感病毒enfeksiyonu sonrasyi özellikle ön boyun bölgesinde ağrı ve hassasiyet gelien olgularda atlanabilen bir tanir olarak SAT gelişebileceğini vurgulamak istemekteyz。
{"title":"Subacute Thyroiditis Associated with COVID-19 Infection: Two Case Reports","authors":"Mustafa Ünübol, Zehra Erdemir, Gokhan Colak, M. Ünsal, Engin Güney","doi":"10.25179/tjem.2021-84279","DOIUrl":"https://doi.org/10.25179/tjem.2021-84279","url":null,"abstract":"Subacute thyroiditis (SAT) is granulomatous thyroiditis of the thyroid gland that usually occurs after a viral infection. Coronavirus disease-2019 (COVID-19) infection has led to a pandemic that has affected the whole world since late 2019. The virus has been reported to cause different extrapulmonary clinical symptoms. Few cases in the literature have reported SAT after COVID-19 viral infection. In this article, 2 cases were diagnosed, where SAT was presented after COVID-19 infection. Using these cases, we aimed to emphasize that patients who present with pain and tenderness in the anterior neck region after COVID-19 infection may develop SAT, whose diagnosis can be missed. Subakut tiroidit (SAT), genellikle bir viral enfeksiyondan sonra ortaya çıkan tiroid bezinin granülomatöz bir tiroiditidir. Koronavirüs hastalığı-2019 [coronavirus disease-2019 (COVID-19)] enfeksiyonu, 2019 yılının sonundan beri tüm dünyayı etkileyen bir pandemiye yol açmıştır. Ekstrapulmoner birçok farklı klinik tabloya yol açtığı bildirilmiştir. COVID-19 viral enfeksiyonu sonrasında SAT bildirilen olgular literatürde az sayıdadır. Bu yazıda, COVID-19 enfeksiyonu sonrası SAT tanısı olan 2 olgu sunuldu. Bu olgular ile birlikte COVID-19 enfeksiyonu sonrası özellikle ön boyun bölgesinde ağrı ve hassasiyet gelişen olgularda atlanabilen bir tanı olarak SAT gelişebileceğini vurgulamak istemekteyiz.","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114902589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2021-84943
Burak Özbaş, Ö. Canöz, Z. Güven, İzzet Ökçesiz, H. Dursun, A. Selçuklu, H. Yilmaz, Z. Karaca, K. Ünlühızarcı
Division of Endocrinology and Metabolism, Erciyes University Faculty of Medicine, Kayseri, TURKIYE *Department of Pathology, Erciyes University Faculty of Medicine, Kayseri, TURKIYE **Division of Hematology, Erciyes University Faculty of Medicine, Kayseri, TURKIYE ***Department of Radiology, Erciyes University Faculty of Medicine, Kayseri, TURKIYE ****Department of Neurosurgery, Erciyes University Faculty of Medicine, Kayseri, TURKIYE *****Department of Internal Medicine, Erciyes University Faculty of Medicine, Kayseri, TURKIYE Case Report Turk J Endocrinol Metab. 2022;26:55-60
{"title":"Pituitary Gland as a Rare Primary Localization of Lymphoma","authors":"Burak Özbaş, Ö. Canöz, Z. Güven, İzzet Ökçesiz, H. Dursun, A. Selçuklu, H. Yilmaz, Z. Karaca, K. Ünlühızarcı","doi":"10.25179/tjem.2021-84943","DOIUrl":"https://doi.org/10.25179/tjem.2021-84943","url":null,"abstract":"Division of Endocrinology and Metabolism, Erciyes University Faculty of Medicine, Kayseri, TURKIYE *Department of Pathology, Erciyes University Faculty of Medicine, Kayseri, TURKIYE **Division of Hematology, Erciyes University Faculty of Medicine, Kayseri, TURKIYE ***Department of Radiology, Erciyes University Faculty of Medicine, Kayseri, TURKIYE ****Department of Neurosurgery, Erciyes University Faculty of Medicine, Kayseri, TURKIYE *****Department of Internal Medicine, Erciyes University Faculty of Medicine, Kayseri, TURKIYE Case Report Turk J Endocrinol Metab. 2022;26:55-60","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"54 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120966696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2020-75230
Suleyman Emre Kocyigit, M. Şahin, Y. Houshyar, F. Günay, D. Çorapçıoğlu
{"title":"Effects of Isotretinoin Treatment on Levels of Hormones Involved in the Etiopathogenesis of Acne","authors":"Suleyman Emre Kocyigit, M. Şahin, Y. Houshyar, F. Günay, D. Çorapçıoğlu","doi":"10.25179/tjem.2020-75230","DOIUrl":"https://doi.org/10.25179/tjem.2020-75230","url":null,"abstract":"","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121854694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2021-83912
S. Saha, Sujata Saha
Introduction Type 1 diabetes mellitus (T1DM) is primarily a childhood-onset hyperglycemic autoimmune condition resulting from the death of pancreatic beta cells. It’s triggered by genetic predisposition (human leukocyte antigen alleles such as DQ and DR) or viruses or environmental toxins, and other unknown factors (1,2). These patients are at risk of hyperglycemic complications such as diabetic retinopathy, diabetic nephropathy, diabetic neuropathy, diabetic ketoacidosis, and As the efficacy and safety of empagliflozin remain poorly studied in Type 1 diabetes mellitus (T1DM) patients, this narrative-systematic review aims to review it. The randomized controlled trials studying the above across different empagliflozin dosages and placebo got searched in PubMed, Embase, and Scopus databases. The database searches yielded 5 eligible trials reporting data of about 1,870 T1DM patients from 45 countries. The empagliflozin dosages tested in these trials were 2.5, 10, and 25 mg. The trials collectively showed a low or unclear risk of bias (Cochrane tool used). The existing double-blinded randomized controlled trials mainly suggest a dose-dependent decrease in glycated hemoglobin, body weight, and total weekly insulin requirement in empagliflozin-treated T1DM patients. Ketoacidosis, urinary tract infection, and study discontinuation due to side effects were rare adverse effects of empagliflozin. Genital infection predominantly occurred among recipients of 10 or 25 mg empagliflozin.
{"title":"Efficacy and Safety of Empagliflozin in Type 1 Diabetes Mellitus Patients: A Systematic Review","authors":"S. Saha, Sujata Saha","doi":"10.25179/tjem.2021-83912","DOIUrl":"https://doi.org/10.25179/tjem.2021-83912","url":null,"abstract":"Introduction Type 1 diabetes mellitus (T1DM) is primarily a childhood-onset hyperglycemic autoimmune condition resulting from the death of pancreatic beta cells. It’s triggered by genetic predisposition (human leukocyte antigen alleles such as DQ and DR) or viruses or environmental toxins, and other unknown factors (1,2). These patients are at risk of hyperglycemic complications such as diabetic retinopathy, diabetic nephropathy, diabetic neuropathy, diabetic ketoacidosis, and As the efficacy and safety of empagliflozin remain poorly studied in Type 1 diabetes mellitus (T1DM) patients, this narrative-systematic review aims to review it. The randomized controlled trials studying the above across different empagliflozin dosages and placebo got searched in PubMed, Embase, and Scopus databases. The database searches yielded 5 eligible trials reporting data of about 1,870 T1DM patients from 45 countries. The empagliflozin dosages tested in these trials were 2.5, 10, and 25 mg. The trials collectively showed a low or unclear risk of bias (Cochrane tool used). The existing double-blinded randomized controlled trials mainly suggest a dose-dependent decrease in glycated hemoglobin, body weight, and total weekly insulin requirement in empagliflozin-treated T1DM patients. Ketoacidosis, urinary tract infection, and study discontinuation due to side effects were rare adverse effects of empagliflozin. Genital infection predominantly occurred among recipients of 10 or 25 mg empagliflozin.","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125320490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2021-83764
S. Kisioglu, V. Bayraktar, Damla Tüfekçi, Yasemin EMUR GÜNAY, M. Kocak, I. Nuhoglu, H. Coskun, S. Karakullukçu, H. Önder Ersöz
{"title":"Efficacy and Side Effect Profile of Empagliflozin and Dapagliflozin in Combination Therapy: A Real-World Experience","authors":"S. Kisioglu, V. Bayraktar, Damla Tüfekçi, Yasemin EMUR GÜNAY, M. Kocak, I. Nuhoglu, H. Coskun, S. Karakullukçu, H. Önder Ersöz","doi":"10.25179/tjem.2021-83764","DOIUrl":"https://doi.org/10.25179/tjem.2021-83764","url":null,"abstract":"","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120959710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2019-71318
H. Düğer, M. Çalapkulu, B. Uçan, E. Çakal, M. Özbek, D. Yılmazer, K. Doğan, M. Sencar
{"title":"Coexistence of Primary Mucosa-Associated Lymphoid Tissue Lymphoma of Thyroid and Papillary Thyroid Microcarcinoma in a Background of Hashimoto’s Thyroiditis","authors":"H. Düğer, M. Çalapkulu, B. Uçan, E. Çakal, M. Özbek, D. Yılmazer, K. Doğan, M. Sencar","doi":"10.25179/tjem.2019-71318","DOIUrl":"https://doi.org/10.25179/tjem.2019-71318","url":null,"abstract":"","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126353976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2019-66735
M. Şahin, A. Oguz, D. Tuzun, C. Ülgen, Semiha Çalkaya, O. Gungor, F. Yazar, K. Gul
{"title":"Therapeutic Plasmapheresis in Amiodarone-Induced Thyrotoxicosis Resistant to Medical Therapy","authors":"M. Şahin, A. Oguz, D. Tuzun, C. Ülgen, Semiha Çalkaya, O. Gungor, F. Yazar, K. Gul","doi":"10.25179/tjem.2019-66735","DOIUrl":"https://doi.org/10.25179/tjem.2019-66735","url":null,"abstract":"","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"59 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128454630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2021-84564
Başak ÖZGEN SAYDAM, S. C. Adiyaman, Berfu Yeşi̇lli̇, A. Bektaş, Özgül Vatansever, Nalan Aydin, Simge Ruhiye Yilmaz Kavcar, Canan Deği̇rmenci̇, F. Bayraktar, B. Akıncı
Objective: Simultaneous teamwork is an advanced collaboration subtype that includes the patient’s evaluation by the team members (including physician, nurse and dietician) together in the same session. Our study aimed to investigate the effect of a simultaneous teamwork approach on metabolic and clinical outcomes of patients with Type 1 diabetes using an insulin pump. Material and Methods: This retrospective study included 49 previous insulin pump users with Type 1 diabetes who participated in a simultaneous teamwork protocol. Metabolic and clinical parameters were collected before and after the teamwork approach. A separate analysis of 16 patients in whom insulin pump was initiated with simultaneous teamwork and pregnancy data from 9 patients were also reported. Results: Simultaneous teamwork resulted in a significant reduction in the frequency of hypoglycemic episodes in previous insulin pump users with Type 1 diabetes. Hemoglobin A1c decreased, but the difference was statistically insignificant. Simultaneous teamwork was also efficient on patients initiated an insulin pump and for pregnancy follow-up in 2 separate subsets of patients with Type 1 diabetes. Conclusion: The simultaneous teamwork approach is a practical method to manage Type 1 diabetes in insulin pump users with the potential to reduce the frequency of hypoglycemic episodes.
{"title":"Simultaneous Teamwork May Improve Hypoglycemia Rates in Patients with Type 1 Diabetes Using an Insulin Pump","authors":"Başak ÖZGEN SAYDAM, S. C. Adiyaman, Berfu Yeşi̇lli̇, A. Bektaş, Özgül Vatansever, Nalan Aydin, Simge Ruhiye Yilmaz Kavcar, Canan Deği̇rmenci̇, F. Bayraktar, B. Akıncı","doi":"10.25179/tjem.2021-84564","DOIUrl":"https://doi.org/10.25179/tjem.2021-84564","url":null,"abstract":"Objective: Simultaneous teamwork is an advanced collaboration subtype that includes the patient’s evaluation by the team members (including physician, nurse and dietician) together in the same session. Our study aimed to investigate the effect of a simultaneous teamwork approach on metabolic and clinical outcomes of patients with Type 1 diabetes using an insulin pump. Material and Methods: This retrospective study included 49 previous insulin pump users with Type 1 diabetes who participated in a simultaneous teamwork protocol. Metabolic and clinical parameters were collected before and after the teamwork approach. A separate analysis of 16 patients in whom insulin pump was initiated with simultaneous teamwork and pregnancy data from 9 patients were also reported. Results: Simultaneous teamwork resulted in a significant reduction in the frequency of hypoglycemic episodes in previous insulin pump users with Type 1 diabetes. Hemoglobin A1c decreased, but the difference was statistically insignificant. Simultaneous teamwork was also efficient on patients initiated an insulin pump and for pregnancy follow-up in 2 separate subsets of patients with Type 1 diabetes. Conclusion: The simultaneous teamwork approach is a practical method to manage Type 1 diabetes in insulin pump users with the potential to reduce the frequency of hypoglycemic episodes.","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131743598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：